Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
TORCH - ELISA
ETI-TOXOK-A reverse PLUS |
P002039/96 Wells |
Intended use |
For the quantitative determination of IgA Antibodies to Toxoplasma gondii. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Calibrators |
5 vials (0-160 AU/mL) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Monoclonal Antibody. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-TOXOK-G PLUS |
P002034/192 Wells |
Intended use |
For the quantitative/qualitative determination of IgG Antibodies to Toxoplasma gondii. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Calibrators |
5 vials (0-250 IU/mL: WHO 3rd International Standard Preparation, 1994) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
2-point calibration curve available, Monoclonal Antibody. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-TOXOK-M reverse PLUS |
P002038/96 Wells |
Intended use |
For the qualitative determination of IgM Antibodies to Toxoplasma gondii. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three Controls (positive, negative, cut-off) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Monoclonal Antibody. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-RUBEK-G PLUS |
P002037/192 Wells |
Intended use |
For the quantitative/qualitative determination of IgG Antibodies to Rubella virus. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Calibrators |
5 vials ( 0-200 IU/mL: WHO 1st IS RUBI-1-94 NIBSC,1977) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
2-point calibration curve available. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-RUBEK-M reverse PLUS |
P002036/96 Wells |
Intended use |
For the qualitative determination of IgM Antibodies to Rubella Virus. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three Controls (positive, negative, cut-off) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Monoclonal Antibody. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-CYTOK-G PLUS |
P002033/192 Wells |
Intended use |
For the quantitative/qualitative determination of IgG Antibodies to human Cytomegalovirus. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Calibrators |
5 vials (0-10 IU/mL:proposed WHO Standard Preparation, 1995) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
2-point calibration curve available, Monoclonal Antibody. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-CYTOK-M reverse PLUS |
P002035/96 Wells |
Intended use |
For the qualitative determination of IgM Antibodies to human Cytomegalovirus. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three Controls (positive, negative, cut-off) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Monoclonal Antibody. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-HSVK-G 1/2 (HSV-1/2 IgG) |
P002023/96 Wells |
Intended use |
For the qualitative determination of IgG Antibodies to Herpes simplex Virus, Types 1/2. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three Controls (positive, negative, cut-off) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant gB-1 protein. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-HSVK-G 2 (HSV-2 IgG) |
P002024/96 Wells |
Intended use |
For the qualitative determination of IgG Antibodies to Herpes simplex Virus, Type 2. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three Controls (positive, negative, cut-off) |
Incubations |
1 h + 1 h/37°C |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant gG2 protein. |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
ETI-HSVK-M 1/2 (HSV-1/2 IgM) |
P002025/96 Wells |
Intended use |
For the qualitative determination of IgM Antibodies to Herpes simplex Virus, Types 1/2. |
Label |
HRP |
Method |
ELISA (Break-away Wells) |
Controls included |
Three Controls (positive, negative, cut-off) |
Incubations |
1 h + 1 h/37°C. |
Chromogen/Substrate |
TMB |
Sample type |
Serum/Plasma |
Sample size |
100 µL (1:101 dilution) |
HSV Type 1 rec. gG1 IgG |
HSV1G0500/96 wells |
Intended use |
For the qualitative and semi-quantitative determination of IgG antibodies against Herpes simplex virus type 1 |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant Antigens |
Sample type |
Serum or plasma |
Sample size |
100 µL (1:101) |
HSV Type 1 rec. gG1 IgM |
HSV1M0500/96 wells |
Intended use |
For the qualitative and semi-quantitative determination of IgM antibodies against Herpes simplex virus type 1 |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant Antigens |
Sample type |
Serum or plasma |
Sample size |
100 µL (1:101) |
HSV Type 2 rec. gG2 IgG |
HSV2G0540/96 wells |
Intended use |
For the qualitative and semi-quantitative determination of IgG antibodies against Herpes simplex virus type 2 |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant Antigens |
Sample type |
Serum or plasma |
Sample size |
100 µL (1:101) |
HSV Type 2 rec. gG2 IgM |
HSV2M0540/96 wells |
Intended use |
For the qualitative and semi-quantitative determination of IgM antibodies against Herpes simplex virus type 2 |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Feature & benefits |
Recombinant Antigens |
Sample type |
Serum or plasma |
Sample size |
100 µL (1:101) |
Herpes Simplex Virus Type 1+2 |
HSVG0250/96 wells |
Intended use |
For the qualitative and semi-quantitative determination of IgG antibodies against Herpes simplex virus type 1+ 2 |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum or plasma |
Sample size |
100 µL (1:101) |
Herpes Simplex Virus Type 1+2 |
HSVM0250/96 wells |
Intended use |
For the qualitative and semi-quantitative determination of IgM antibodies against Herpes simplex virus type 1+ 2 |
Label |
HRP |
Method |
ELISA (Break-away wells) |
Controls included |
Three levels (positive, negative, cut-off) |
Incubations |
1 h/ 37°C + 30 min/RT |
Chromogen/Substrate |
TMB |
Sample type |
Serum or plasma |
Sample size |
100 µL (1:101) |


